Latest Breaking News On - Paula ragan - Page 1 : comparemela.com

FY2028 EPS Estimates for X4 Pharmaceuticals, Inc (NASDAQ:XFOR) Boosted by HC Wainwright

FY2028 EPS Estimates for X4 Pharmaceuticals, Inc (NASDAQ:XFOR) Boosted by HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Adams mostafaPaula raganStonepine capital managementSecurities exchange commissionPharmaceuticals incPharmaceuticals stock performancePharmaceuticals dailyBain capital life sciences investorsCapital partnersBarclays plcFree reportGet free reportCapital life sciences investorsCapital managementExchange commission

Brokers Set Expectations for X4 Pharmaceuticals, Inc s FY2028 Earnings (NASDAQ:XFOR)

Brokers Set Expectations for X4 Pharmaceuticals, Inc s FY2028 Earnings (NASDAQ:XFOR)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Paula raganAdams mostafaBarclays plcCapital partnersPharmaceuticals incPharmaceuticals dailyPharmaceuticals stock performanceSg americas securitiesStonepine capital managementSecurities exchange commissionFree reportGet free reportCapital managementExchange commission

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results And Provides Corporate Updates

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results And Provides Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesPaula raganAmerican society of hematologyPharmaceuticals nasdaqDevelopment rd expensesDrug administrationClinical immunology societyEuropean medicines agencyChief executive officerRare pediatric disease priority review voucherKey anticipated upcoming milestonesAmerican societyCash equivalentsRestricted cashShort term marketable securitiesPriority review voucher

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPaula raganHead of corporate patient affairsEuropean medicines agencyExchange commissionAmerican society of hematologyClinical immunology societyDrug administrationDevelopment rd expensesPharmaceuticals reports firstPharmaceuticals nasdaqCompany contactReports first quarterProvides corporateChief executive officerRare pediatric disease priority review voucher

X4 Pharmaceuticals (NASDAQ:XFOR) Price Target Increased to $5 00 by Analysts at HC Wainwright

X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price lifted by equities researchers at HC Wainwright from $3.00 to $5.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 352.49% from the company’s […]

Paula raganAdams mostafaSecurities exchange commissionPharmaceuticals stock performanceCapital partnersPharmaceuticals company profilePharmaceuticals dailyStonepine capital managementPharmaceuticals incBain capital life sciences investorsSg americas securitiesGet free reportExchange commissionCapital life sciences investorsCapital managementX4 pharmaceuticals